Alive Lifescience Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-12-2024
- Paid Up Capital ₹ 5.00 M
as on 30-12-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.40 M
as on 30-12-2024
- Revenue -15.26%
(FY 2021)
- Profit -44.16%
(FY 2021)
- Ebitda -5.17%
(FY 2021)
- Net Worth 5.64%
(FY 2021)
- Total Assets 17.47%
(FY 2021)
About Alive Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹2.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Beena Karbhari, Hetal Nanavati, and Manthan Nanavati serve as directors at the Company.
- CIN/LLPIN
U24230GJ2008PTC055191
- Company No.
055191
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alive Lifescience Private Limited offer?
Alive Lifescience Private Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Common Disease Medicines, Ointment.
Who are the key members and board of directors at Alive Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manthan Nanavati  | Director | 15-May-2021 | Current |
| Beena Karbhari | Director | 07-Oct-2008 | Current |
| Hetal Nanavati | Director | 08-Jun-2021 | Current |
Financial Performance of Alive Lifescience.
Alive Lifescience Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 15.26% decrease. The company also saw a substantial fall in profitability, with a 44.16% decrease in profit. The company's net worth moved up by a moderate rise of 5.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alive Lifescience?
In 2021, Alive Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Sep 2010 | ₹2.40 M | Satisfied |
How Many Employees Work at Alive Lifescience?
Alive Lifescience has a workforce of 30 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alive Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alive Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
